China · Delayed Price · Currency is CNY Shanghai ZJ Bio-Tech Statistics
Total Valuation
SHA:688317 has a market cap or net worth of CNY 2.73 billion. The enterprise value is 258.53 million.
| Market Cap | 2.73B |
| Enterprise Value | 258.53M |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688317 has 170.98 million shares outstanding. The number of shares has decreased by -9.23% in one year.
| Current Share Class | 170.98M |
| Shares Outstanding | 170.98M |
| Shares Change (YoY) | -9.23% |
| Shares Change (QoQ) | -12.25% |
| Owned by Insiders (%) | 0.41% |
| Owned by Institutions (%) | 8.08% |
| Float | 96.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.97 |
| PB Ratio | 0.85 |
| P/TBV Ratio | 0.86 |
| P/FCF Ratio | 136.69 |
| P/OCF Ratio | 62.94 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 12.97 |
Financial Position
The company has a current ratio of 25.91, with a Debt / Equity ratio of 0.09.
| Current Ratio | 25.91 |
| Quick Ratio | 25.44 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | 14.58 |
| Interest Coverage | -56.04 |
Financial Efficiency
Return on equity (ROE) is -1.91% and return on invested capital (ROIC) is -10.46%.
| Return on Equity (ROE) | -1.91% |
| Return on Assets (ROA) | -1.35% |
| Return on Invested Capital (ROIC) | -10.46% |
| Return on Capital Employed (ROCE) | -2.26% |
| Weighted Average Cost of Capital (WACC) | 7.61% |
| Revenue Per Employee | 441,041 |
| Profits Per Employee | -234,603 |
| Employee Count | 269 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.46 |
Taxes
| Income Tax | -9.21M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.47% in the last 52 weeks. The beta is 0.75, so SHA:688317's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | -29.47% |
| 50-Day Moving Average | 17.13 |
| 200-Day Moving Average | 18.55 |
| Relative Strength Index (RSI) | 40.19 |
| Average Volume (20 Days) | 1,985,160 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688317 had revenue of CNY 118.64 million and -63.11 million in losses. Loss per share was -0.37.
| Revenue | 118.64M |
| Gross Profit | 98.21M |
| Operating Income | -79.03M |
| Pretax Income | -72.32M |
| Net Income | -63.11M |
| EBITDA | -17.80M |
| EBIT | -79.03M |
| Loss Per Share | -0.37 |
Balance Sheet
The company has 2.76 billion in cash and 290.71 million in debt, with a net cash position of 2.47 billion or 14.43 per share.
| Cash & Cash Equivalents | 2.76B |
| Total Debt | 290.71M |
| Net Cash | 2.47B |
| Net Cash Per Share | 14.43 |
| Equity (Book Value) | 3.22B |
| Book Value Per Share | 20.06 |
| Working Capital | 2.73B |
Cash Flow
In the last 12 months, operating cash flow was 43.30 million and capital expenditures -23.36 million, giving a free cash flow of 19.94 million.
| Operating Cash Flow | 43.30M |
| Capital Expenditures | -23.36M |
| Depreciation & Amortization | 61.23M |
| Net Borrowing | 89.82M |
| Free Cash Flow | 19.94M |
| FCF Per Share | 0.12 |
Margins
Gross margin is 82.78%, with operating and profit margins of -66.61% and -53.19%.
| Gross Margin | 82.78% |
| Operating Margin | -66.61% |
| Pretax Margin | -60.96% |
| Profit Margin | -53.19% |
| EBITDA Margin | -15.00% |
| EBIT Margin | -66.61% |
| FCF Margin | 16.81% |
Dividends & Yields
SHA:688317 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 9.23% |
| Shareholder Yield | 9.23% |
| Earnings Yield | -2.31% |
| FCF Yield | 0.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |